TIM-3 is expressed on activated human CD4+ T cells and regulates Th1 and Th17 cytokines

被引:289
作者
Hastings, William D. [1 ]
Anderson, David E. [1 ]
Kassam, Nasim [1 ]
Koguchi, Ken [1 ]
Greenfield, Edward A. [1 ]
Kent, Sally C. [1 ]
Zheng, Xin Xiao [2 ,3 ]
Strom, Terry B. [2 ,3 ]
Hafler, David A. [1 ]
Kuchroo, Vijay K. [1 ]
机构
[1] Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Beth Israel & Deaconess Hosp, Div Immunol, Boston, MA USA
[3] Harvard Univ, Sch Med, Beth Israel & Deaconess Hosp, Transplant Res Ctr, Boston, MA USA
基金
美国国家卫生研究院;
关键词
Cell activation; Human; Immunosuppression; T cells; TUMOR-INFILTRATING LYMPHOCYTES; GROWTH-FACTOR-BETA; MULTIPLE-SCLEROSIS; T(H)17 CELLS; RESPONSES; INDUCTION; IMMUNITY; DIFFERENTIATION; AUTOIMMUNE; TOLERANCE;
D O I
10.1002/eji.200939274
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
TIM-3 is a molecule selectively expressed on a subset of murine IFN-gamma-secreting T helper 1 (Th1) cells but not Th2 cells, and regulates Th1 immunity and tolerance in vivo. At this time little is known about the role of TIM-3 on human T cells. To determine if TIM-3 similarly identifies and regulates Th1 cells in humans, we generated a panel of mAb specific for human TIM-3. We report that TIM-3 is expressed by a subset of activated CD4(+) cells, and that anti-CD3/anti-CD28 stimulation increases both the level of expression as well as the number of TIM-3(+) T cells. We also find that TIM-3 is expressed at high levels on in vitro polarized Th1 cells, and is expressed at lower levels on Th17 cells. In addition, human CD4(+) T cells secreted elevated levels of IFN-gamma, IL-17, IL-2, and IL-6, but not IL-10, IL-4, or TNF-alpha, when stimulated with anti-CD3/anti-CD28 in the presence of TIM-3-specific, putative antagonistic antibodies. This was not mediated by differences in proliferation or cell death, but rather by induction of cytokines at the transcriptional level. These results suggest that TIM-3 is a negative regulator of human T cells and regulates Th1 and Th17 cytokine secretion.
引用
收藏
页码:2492 / 2501
页数:10
相关论文
共 29 条
[1]  
Aarvak T, 1999, J IMMUNOL, V162, P1246
[2]  
Albanesi C, 1999, J IMMUNOL, V162, P494
[3]   Th1-Th2: reliable paradigm or dangerous dogma? [J].
Allen, JE ;
Maizels, RM .
IMMUNOLOGY TODAY, 1997, 18 (08) :387-392
[4]   Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cells [J].
Anderson, Ana C. ;
Anderson, David E. ;
Bregoli, Lisa ;
Hastings, William D. ;
Kassam, Nasim ;
Lei, Charles ;
Chandwaskar, Rucha ;
Karman, Jozsef ;
Su, Ee W. ;
Hirashima, Mitsuomi ;
Bruce, Jeffrey N. ;
Kane, Lawrence P. ;
Kuchroo, Vijay K. ;
Hafler, David A. .
SCIENCE, 2007, 318 (5853) :1141-1143
[5]   Phenotypic and functional features of human Th17 cells [J].
Annunziato, Francesco ;
Cosmi, Lorenzo ;
Santarlasci, Veronica ;
Maggi, Laura ;
Liotta, Francesco ;
Mazzinghi, Benedetta ;
Parente, Eliana ;
Fili, Lucia ;
Ferri, Simona ;
Frosali, Francesca ;
Giudici, Francesco ;
Romagnani, Paola ;
Parronchi, Paola ;
Tonelli, Francesco ;
Maggi, Enrico ;
Romagnani, Sergio .
JOURNAL OF EXPERIMENTAL MEDICINE, 2007, 204 (08) :1849-1861
[6]   Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells [J].
Bettelli, E ;
Carrier, YJ ;
Gao, WD ;
Korn, T ;
Strom, TB ;
Oukka, M ;
Weiner, HL ;
Kuchroo, VK .
NATURE, 2006, 441 (7090) :235-238
[7]   Induction and effector functions of TH17 cells [J].
Bettelli, Estelle ;
Korn, Thomas ;
Oukka, Mohamed ;
Kuchroo, Vijay K. .
NATURE, 2008, 453 (7198) :1051-1057
[8]   Mutations in STAT3 and IL12RB1 impair the development of human IL-17-producing T cells [J].
de Beaucoudrey, Ludovic ;
Puel, Anne ;
Filipe-Santos, Orchidee ;
Cobat, Aurelie ;
Ghandil, Pegah ;
Chrabieh, Maya ;
Feinberg, Jacqueline ;
von Bernuth, Horst ;
Samarina, Arina ;
Janniere, Lucile ;
Fieschi, Claire ;
Stephan, Jean-Louis ;
Boileau, Catherine ;
Lyonnet, Stanislas ;
Jondeau, Guillaume ;
Cormier-Daire, Valerie ;
Le Merrer, Martine ;
Hoarau, Cyrille ;
Lebranchu, Yvon ;
Lortholary, Olivier ;
Chandesris, Marie-Olivia ;
Tron, Francois ;
Gambineri, Eleonora ;
Bianchi, Lucia ;
Rodriguez-Gallego, Carlos ;
Zitnik, Simona E. ;
Vasconcelos, Julia ;
Guedes, Margarida ;
Vitor, Artur Bonito ;
Marodi, Laszlo ;
Chapel, Helen ;
Reid, Brenda ;
Roifman, Chaim ;
Nadal, David ;
Reichenbach, Janine ;
Caragol, Isabel ;
Garty, Ben-Zion ;
Dogu, Figen ;
Camcioglu, Yildiz ;
Gulle, Sanyie ;
Sanal, Ozden ;
Fischer, Alain ;
Abel, Laurent ;
Stockinger, Birgitta ;
Picard, Capucine ;
Casanova, Jean-Laurent .
JOURNAL OF EXPERIMENTAL MEDICINE, 2008, 205 (07) :1543-1550
[9]   Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection [J].
Jones, R. Brad ;
Ndhlovu, Lishomwa C. ;
Barbour, Jason D. ;
Sheth, Prameet M. ;
Jha, Aashish R. ;
Long, Brian R. ;
Wong, Jessica C. ;
Satkunarajah, Malathy ;
Schweneker, Marc ;
Chapman, Joan M. ;
Gyenes, Gabor ;
Vali, Bahareh ;
Hyrcza, Martin D. ;
Yue, Feng Yun ;
Kovacs, Colin ;
Sassi, Aref ;
Loutfy, Mona ;
Halpenny, Roberta ;
Persad, Desmond ;
Spotts, Gerald ;
Hecht, Frederick M. ;
Chun, Tae-Wook ;
McCune, Joseph M. ;
Kaul, Rupert ;
Rini, James M. ;
Nixon, Douglas F. ;
Ostrowski, Mario A. .
JOURNAL OF EXPERIMENTAL MEDICINE, 2008, 205 (12) :2763-2779
[10]   Opinion - Consensual immunity: success-driven development of T-helper-1 and T-helper-2 responses [J].
Kalinski, P ;
Moser, M .
NATURE REVIEWS IMMUNOLOGY, 2005, 5 (03) :251-260